Category: Gene Therapy
Global Gene Therapy
-
Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Global Market Report 2024
... 43) By Indication: Oncology; Infectious Diseases; Neurological Disorders; Rare DiseasesCovering: Pfizer Inc; Merck & Co. Inc.; Thermo Fisher Scientific Inc; Novartis AG; FUJIFILM Diosynth Biotechnologies Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) ... Read More
-
Cell Therapy Market. - forecast to 2033 : By CELL TYPE (Stem, T-cell Therapy, Dendritic, Natural Killer, Mesenchymal Stem Cell, Induced Pluripotent Stem Cell), THERAPEUTIC AREA (Oncology, Cardiovascular Disorders, Neurological Disorders, Musculoskeletal Disorders, Autoimmune Disorders, Dermatological Disorders, Others), APPLICATION (Regenerative Medicine, Tissue Engineering, Immunotherapy, Gene Therapy, Cell-based Assays, Others), END-USER (Hospitals & Clinics, Research Institutes, Biotechnology, Pharmaceutical Companies), STAGE OF DEVELOPMENT (Preclinical, Phase I, Phase II, Phase III, Commercialized), TECHNOLOGY (Viral Vector-based, Non-viral Vector-based, Gene Editing Technologies), MODE OF DELIVERY (Intravenous, Intramuscular, Subcutaneous, Others), and Region
... Dermatological Disorders, Others), APPLICATION (Regenerative Medicine, Tissue Engineering, Immunotherapy, Gene Therapy, Cell-based Assays, Others), END-USER (Hospitals & Clinics, Research Institutes, Biotechnology, Pharmaceutical Companies), STAGE OF DEVELOPMENT (Preclinical, Phase I, Phase II, Phase III, Commercialized), TECHNOLOGY ... Read More
-
Gene Therapy Market Assessment, By Type [Gene Augmentation, Gene Silencing, Others], By Vector [Viral Vectors, Non-Viral Vectors], By Gene Delivery Method [In vivo, Ex vivo], By Application [Oncological Diseases, Genetic Diseases, Cardiovascular Diseases, Neuromuscular Diseases, Hematological Diseases, Infectious Diseases, Others], By Route of Administration [Intravenous, Others], By End-user [Hospitals, Cancer and Research Institutes, Clinics, Others], By Region, Opportunities and Forecast, 2017-2031F
... Hematological Diseases, Infectious Diseases, Others], By Route of Administration [Intravenous, Others], By End-user [Hospitals, Cancer and Research Institutes, Clinics, Others], By Region, Opportunities and Forecast, 2017-2031F Global gene therapy market is projected to witness a ... Read More
-
Cell And Gene Therapy Clinical Trial Services Global Market Report 2024
... Monitoring2) By Therapy Type: Gene Therapy; Cell Therapy; Gene Modified Cell Therapy3) By Indication: Oncology; Hematology; Metabolic Disorders; Infectious Diseases; Neurology; Cardiovascular Diseases; Musculoskeletal Disorders4) By End-Use: Pharmaceutical And Biotechnology Companies; Contract Research Organizations; Academic ... Read More
-
Global Optogenetic Retinal Gene Therapy Market Growth (Status and Outlook) 2024-2030
... expected to grow at a CAGR of %from 2024 to 2030. LPI (LP Information)' newest research report, the “Optogenetic Retinal Gene Therapy Industry Forecast” looks at past sales and reviews total world Optogenetic Retinal Gene ... Read More
-
Gene Therapy
... at a CAGR of 23.1% over the analysis period 2023-2030. Viral Gene Therapy, one of the segments analyzed in the report, is expected to record a 23.3% CAGR and reach US$5.5 Billion by the end ... Read More
-
Viral Vector Manufacturing Market Report by Type (Adenoviral Vectors, Adeno-associated Viral Vectors, Lentiviral Vectors, Retroviral Vectors, and Others), Disease (Cancer, Genetic Disorders, Infectious Diseases, and Others), Application (Gene Therapy, Vaccinology), End User (Pharmaceutical and Biopharmaceutical Companies, Research Institutes), and Region 2024-2032
... Companies, Research Institutes), and Region 2024-2032 The global viral vector manufacturing market size reached US$ 1,200.1 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 7,681.6 Million by 2032, exhibiting a ... Read More
-
Cell and Gene Therapy CRO Market (4th Edition)
... and gene therapy candidates have shown promising outcomes in treating rare and complex diseases, including conditions for which effective treatments are currently in development phase. It's essential to note that in cell therapy, human cells ... Read More
-
Cell & Gene Therapy Cold Chain Logistics Market Report 2024-2034
... they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. ... Read More
-
2024 Global: Gene Therapy Market - Innovative Markets Forecast (2030) report
... 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 using regression ... Read More
-
Global Gene Therapy Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Global Gene Therapy Competitive Landscape Professional Research Report 2024
... diseases. This innovative field aims to address the underlying genetic causes of various disorders, including genetic diseases, certain types of cancer, and other conditions with a genetic component. Gene therapy can be achieved by delivering ... Read More
-
Global Rare Disease Treatment Competitive Landscape Professional Research Report 2024
... as orphan diseases, affect a relatively small number of people in the population. Due to their rarity, developing treatments for these conditions can pose significant challenges, including limited research, lack of available therapies, and difficulties ... Read More
-
Global Hemophilia Gene Therapy Competitive Landscape Professional Research Report 2024
... Typically, hemophilia gene therapy involves introducing a functional copy of the clotting factor gene into the patient＇s cells, often using viral vectors as delivery vehicles. The goal is to enable the patient＇s cells to produce ... Read More
-
Global Gene Therapy On Cardiovascular Disease Competitive Landscape Professional Research Report 2024
... approach aims to modify or introduce specific genes to improve the function of the cardiovascular system. In the context of cardiovascular diseases, gene therapy may target conditions such as ischemic heart disease, heart failure, or ... Read More
-
Regenerative Medicine Market by Type (Cell-Based Immunotherapy & Cell Therapy Products, Gene Therapy Products, Small Molecule & Biologic), Application (Cardiovascular, Diabetes, Musculoskeletal Disorders) - Global Forecast 2024-2030
... USD 23.02 billion in 2023 and expected to reach USD 28.35 billion in 2024, at a CAGR 23.76% to reach USD 102.40 billion by 2030. Regenerative medicine is an interdisciplinary field that applies engineering and ... Read More
-
Pancreatic Cancer Therapeutics Market by Type (Endocrine Pancreatic Cancer, Exocrine Pancreatic Cancer), Product (Chemotherapy, Gene Therapy, Immunotherapy), End-Use - Global Forecast 2024-2030
... 2023 and expected to reach USD 5.14 billion in 2024, at a CAGR 9.95% to reach USD 9.09 billion by 2030. Pancreatic cancer therapeutics encompass a variety of treatment modalities used to manage and combat ... Read More
-
Cell & Gene Therapy Manufacturing Services Market by Type (Cell Therapy, Gene Therapy), Indication (Cardiovascular Diseases, Central Nervous System Disorders, Infectious Diseases), Application, End-User - Global Forecast 2024-2030
... Market size was estimated at USD 17.34 billion in 2023 and expected to reach USD 19.98 billion in 2024, at a CAGR 15.81% to reach USD 48.45 billion by 2030. Cell and gene therapy manufacturing ... Read More
-
Viral Vector & Plasmid DNA Manufacturing Market by Type (Plasmid DNA, Viral Vector), Cell Line (In-vitro, In-Vivo), Transfection, Indication, Workflow, Application, End User - Global Forecast 2024-2030
... size was estimated at USD 1.50 billion in 2023 and expected to reach USD 1.88 billion in 2024, at a CAGR 25.34% to reach USD 7.32 billion by 2030. The market of viral vector and ... Read More
-
Gene Therapy Market by Type (Antigen Gene Therapy, Cancer Gene Therapy, Cytokine Gene Therapy), Vector Type (Non-viral Vectors, Viral Vectors), Application - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 7.05 billion in 2024, at a CAGR 27.15% to reach USD 30.48 billion by 2030. Gene therapy is a medical procedure that introduces, alters, or corrects genetic ... Read More
-
Global AAV Vector-Based Gene Therapy Drugs Market Growth (Status and Outlook) 2024-2030
... utilize AAV vectors, which are small, non-enveloped viruses that have a low pathogenic profile and are capable of delivering genetic material into host cells. The genetic material, which be a functional gene or a therapeutic ... Read More
-
Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Progenitor and Stem Cell Therapies), by Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceuticals), and by Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others)– Global Opportunity Analysis and Industry Forecast, 2024 – 2030
... Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others)– Global Opportunity Analysis and Industry Forecast, 2024 – 2030 The Regenerative Medicine Market size was valued at USD 24.85 billion in 2023, and is predicted to reach ... Read More
-
Global LV-Based Cell and Gene Therapy Products Market Growth (Status and Outlook) 2024-2030
... material into target cells. Lentiviral vectors are commonly used in gene therapy to transfer genes into cells for the treatment of genetic disorders, cancer, and other diseases. The global LV-Based Cell and Gene Therapy Products ... Read More
-
Global Viral Vector-Based Gene Therapy Drugs Market Growth (Status and Outlook) 2024-2030
... genetic disorders or diseases. These drugs typically contain modified viruses as vectors to efficiently and safely transfer genetic material into the cells of patients, aiming to correct genetic mutations or induce specific therapeutic effects. The ... Read More
-
Global Retrovirus-Based Gene Therapy Drugs Market Growth (Status and Outlook) 2024-2030
... cancer and other diseases. Retroviruses occur naturally in some animals and can reverse-transcribe RNA into DNA and insert into the genome of host cells. In gene therapy, scientists take advantage of this feature to load ... Read More
Research Assistance
